Pfizer will/can wait until this company is financially on its knees.
RAP are out of loot, hence research grinds to a halt, and marketing deteriorates. They have a potential distribution channel in place but without a massive Pfizer the whole system will grind to a halt.
Where are the retail investors going to get another $50m plus and then pay for an expanded research/administrative team etc etc.
Pipe dream
Thank you lucky stars that Pfizer have arrived to put some wheels on this bike.
You should be giving this move a big YES and get it over the line ASAP
- Forums
- ASX - By Stock
- RAP
- Ann: Medgate extends licence agreement and plans to expand use
Ann: Medgate extends licence agreement and plans to expand use, page-59
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 93 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)